Dr. Gish is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1580 Creekside Dr
Ste 220
Folsom, CA 95630Phone+1 916-986-4444Fax+1 916-983-8563
Summary
- Dr. Gish is a fellow of the American Association for the Study of Liver Disease.
He has served on the editorial boards of American Journal of Gastroenterology, Hepatology, Journal of Hepatology, Digestive Diseases and Sciences, and Gastroenterology, among many others. He has co-authored a public health policy for liver health in Vietnam focusing on HBV and is also assisting with the development of viral hepatitis health care policies in Armenia and the Philippines. He was a major early contributor to decipherment methods for the detection of hepatitis B and C virus and characterizing its epidemiology and clinical presentation in humans. He was involved in studies that led to the genotypic classification strategies and methods now in use worldwide. He has published more than 700 original articles, review articles, abstracts, and book chapters.
Robert G. Gish, MD, is currently an Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno. He serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD and Professor of Medicine at Loma Linda University. In addition, he is also Medical Director of the Hepatitis B Foundation in Doylestown, Pennsylvania.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1984 - 1988
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1980 - 1981
- University of Kansas School of MedicineClass of 1980
- University of KansasBachelor's, Pharmaceutical Sciences, 1973 - 1977
Certifications & Licensure
- CA State Medical License 1981 - 2026
- NV State Medical License 2019 - 2025
- FL State Medical License 2019 - 2021
- AZ State Medical License 2014 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- San Diego’s Top Doctors Annual List San Diego County Medical Society, 2013
- Top Doctor of 2013 American Registry, 2013
- Diversity Pioneer Award 2012
- Join now to see all
Clinical Trials
- Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 4 citationsPrimary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, Marco Carbone, Emma Culver
Hepatology. 2024-11-01 - 4 citationsReview of current and new drugs for the treatment of metabolic-associated fatty liver disease.Robert Gish, Jian-Gao Fan, Zahra Dossaji, Jeanne Fichez, Tooba Laeeq
Hepatology International. 2024-10-01 - Reply: The causal analysis of missing confounding factors for the association between HDV and specific liver events.Robert G Gish, Robert J Wong, Gian Luca Di Tanna, Ankita Kaushik, Chong Kim
Hepatology. 2024-10-01
Journal Articles
- Hepatic Encephalopathy is Associated with Significantly Increased Mortality Among Patients Awaiting Liver TransplantationWong RJ, Gish, RG, Aijaz, A, Wong RJ, Gish, RG, Aijaz, A, 6/8/2014
- Implementing Best Practices When Initiating Hepatitis B Virus TherapyWong RJ, Gish RG, Clin in Liv Dis, 4/1/2014
- A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluationGish RG, Gutierrez JA, Navarro-Cazarez N, Giang K, Adler D, Tran B, Locarnini S, Ham-mond R, Bowden S, Journal of Viral Hep, 3/15/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Collaborative Efforts to screen at risk populations for hepatitis B and C in San Diego CountyGish, RG, Tran B, Nyguyen C, Pharm D, Singapore Hepatitis Conference 2014, 6/5/2014
- Pearls gained from hepatitis B screening in the Community settingGish, RG, Tran B, Nyguyen C, Pharm D, Singapore Hepatitis Conference 2014, 6/5/2014
- Targeting populations at risk for hepatitis B using the Research Electronic Data Capture Program (REDCap)Gish, RG, Tran B, Nyguyen C, Pharm D., Singapore Hepatitis Conference 2014, 6/5/2014
- Join now to see all
Lectures
- Liver Failure: How to Have your Patients Survive until Liver Transplant: A Roadmap to Life, Scripps Center for Organ Transplantation7/18/2014
- Vietnam and the growing Hepatitis problem in the Asian community5/29/2014
- GI Tumor Conference5/22/2014
- Join now to see all
Press Mentions
- Cutting down Medi-Cal Managed Care Plans Is Big MistakeFebruary 23rd, 2022
- Universal Screening for Hepatitis DeltaDecember 20th, 2021
- Not All Californians Can Get Life-Saving Hepatitis C Treatment. Governor's Budget Aims to FixJune 27th, 2018
- Join now to see all
Professional Memberships
- Fellow
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: